深圳機場(000089.SZ):擬對運輸公司實施清算註銷
格隆匯10月20日丨深圳機場(000089.SZ)公佈,為提升深圳機場地面交通集疏運保障能力,打造與深圳機場國際航空樞紐地位相匹配的地面交通運輸服務體系,深圳機場與深圳巴士集團股份有限公司(以下簡稱巴士集團)開展戰略合作,將深圳市機場運輸有限公司(以下簡稱運輸公司)業務移交巴士集團,運輸公司停止運營。按照政府部門有關清退不具備競爭優勢的非主營業務(企業)和低效無效資產的要求,擬對運輸公司實施清算註銷。公司於2021年10月20日召開第八屆董事會第一次臨時會議,會議審議通過了《關於清算註銷控股子公司的議案》,同意對運輸公司進行清算註銷處置,授權經理層依照相關規定辦理清算註銷的具體事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.